Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The Wall Street Journal reported Aug. 3. Two provisions in the law will delay Medicare price negotiations for some of the best-selling drugs in […]
